Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2003
12/10/2003CN1130364C Deuteroporphyvin derivative, its preparing method and freeze dried preparation for injection
12/10/2003CN1130362C Nucleosides analogues, such as antivirals including inhititors of retroviral reverse transcriptase and DNA polymerase of heaptitis B virus (HBV)
12/10/2003CN1130361C Process for producing isooxazolidinedione compound
12/10/2003CN1130359C Substituted benzimidazole, its preparation and use as means against parastic protozoa
12/10/2003CN1130358C Imidzzole compounds and preparing method and application thereof
12/10/2003CN1130356C Partially synthetic seco-taxinane with antitumour activity
12/10/2003CN1130355C Thienyl-, furyl-, pyrrolyl-and biphenylsulfonamides and derivatives thereof modulate activity of endothelin
12/10/2003CN1130349C H3 receptor liqands of phenyl-alkyl-imidazoles type
12/10/2003CN1130347C 2,3-methylene amino acid compounds, their preparing method and pharmaceutical composition containing them
12/10/2003CN1130346C Tetrahydroquinolines as NMDA antagonists
12/10/2003CN1130345C Amino quinoline derivatives
12/10/2003CN1130310C Improved method for preparing low-concentration polyaluminosilicate microgels
12/10/2003CN1130223C Pharmaceutical formulation containing growth hormone, amino acid and non-ionic detergent
12/10/2003CN1130222C Aqueous prolonged release formulation
12/10/2003CN1130213C Chinese herbal plaster for anti-canser and analgesic
12/10/2003CN1130207C Ointment for bone injury and its preparing method
12/10/2003CN1130205C Biochemically balanced peritoneal dialysis solutions
12/10/2003CN1130204C Pharmaceutical composition with antimicrobial activty
12/10/2003CN1130203C Injectable formulations of avermectins and milbemycins
12/10/2003CN1130202C Compound nose drops and its preparation method
12/10/2003CN1130201C Synergistic gold-containing compositions
12/10/2003CN1130200C Glucocorticoid receptor antagonists for treatment of dementia
12/10/2003CN1130199C Improved method of synthesis for 6,9-bis[(2-aminoethyl)amino] benzo[g] isoquinoline-5,10-dione and its dimaleate salt
12/10/2003CN1130198C Appliance of Ampelopsis grossedentata total flavone for curing oral ulcer
12/10/2003CN1130197C Implanted slow-releasing antiseptic preparation and its preparing method
12/10/2003CN1130194C Solid pharmaceutical preparation
12/09/2003US6660891 Methods for the production of D-chiro-inositol and the use of D-chiro inositol obtained therefrom
12/09/2003US6660879 Use of the compound in clinical conditions associated with insulin resistance.
12/09/2003US6660873 Method for the preparation of citalopram
12/09/2003US6660866 C10 carbonate substituted taxanes
12/09/2003US6660862 Genetic engineering
12/09/2003US6660859 Arylpiperzine derivatives are useful for treatment of anxiety, depression, hypertension, cognitive disorders, sexual dysfunction, brain trauma, memory loss, eating disorders, obesity, substance abuse, and obsessive-compulsive diseases
12/09/2003US6660845 Non-aggregating, non-quenching oligomers comprising nucleotide analogues; methods of synthesis and use thereof
12/09/2003US6660777 Comprehensive pharmacologic therapy for treatment of obesity
12/09/2003US6660774 Use of (+)-tramadol, O-demethyltramadol or (+)-O-demethyl-tramadol, O-desmethyl-N-mono-desmethyl-tramadol or (+)- O-desmethyl-N-mono-desmethyltramadol
12/09/2003US6660772 Use of 2-amino-1-(4-hydroxy-2-methanesulfonamidophenyl)ethanol for treating urinary incontinence
12/09/2003US6660771 Remedies for liver regeneration of transplanted liver
12/09/2003US6660769 The presence of a substituted amine functional group in the C-3 position of 2,2-dialkyl-1,4-butyrolactones leads to a greater enhancement in GABA effects
12/09/2003US6660768 Parasiticidal compositions and methods of use
12/09/2003US6660767 Coumarin compounds as microtubule stabilizing agents and therapeutic uses thereof
12/09/2003US6660766 Bioavailability
12/09/2003US6660765 FC101 as a method of treatment for cancer
12/09/2003US6660763 Bis-indolylquinone compounds
12/09/2003US6660762 Methods and compositions to treat lung diseases
12/09/2003US6660761 Method of treatment for fungal infections with a synergistic formulation of antifungal agents
12/09/2003US6660760 Heterocyclic aromatic compounds useful as growth hormone secretagogues
12/09/2003US6660759 4.5-diaryloxazole compounds with prostaglandin I2 (PGI2) agonistic activity
12/09/2003US6660757 Use of riluzole in the treating acoustic traumas
12/09/2003US6660754 Method for reducing or eliminating smoking
12/09/2003US6660752 2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
12/09/2003US6660751 Sulfonamide derivatives as 5-HT7 receptor antagonists
12/09/2003US6660750 Inhibits the cyclin-dependent kinase subunit of P-TEFb (positive transcription elongation factor b) required for HIV propagation and replication in human cells; low dosages; side effects reduction; AIDS
12/09/2003US6660749 Administering a dideoxy-imino-glucitol
12/09/2003US6660748 1-azabicyclo(2.2.1)heptane or quinuclidine derivatives; treating or preventing neuronal damage associated with neurological diseases
12/09/2003US6660746 Cardiovascular disorders
12/09/2003US6660745 Phosphodiesterase inhibitors; treatment of asthma, chronic obstructive pulmonary disease, inflammatory disorders
12/09/2003US6660744 Pyrazolopyrimidines as therapeutic agents
12/09/2003US6660743 Improved stability
12/09/2003US6660742 Alkylation therapy; anticancer agent
12/09/2003US6660741 Coupling an O-protected methoxypyrrolidine or derivatives with N-protected amino acid 2,5-dioxo-pyrrolidinyl ester to form intermediate, deportecting with trifluoroacetic acid to form pyrrolidine-1-carbonyl-2-methylamine or derivatives
12/09/2003US6660740 Sorbitol dehydrogenase inhibitors
12/09/2003US6660739 Heterocyclic amides as inhibitors of factor Xa
12/09/2003US6660738 Such as (3R,5S)-1-pyrimidin-2-yl-5-(2,4,5-trifluoro-benzyloxymethyl)-pyrrolidine-3 -thiol trifluoro-acetate useful as inhibitors of metalloproteases for treating diseases associated with vasoconstriction
12/09/2003US6660737 Medicinal uses of hydrazones
12/09/2003US6660736 MAO-B inhibitors
12/09/2003US6660735 Urea substituted imidazoquinoline ethers
12/09/2003US6660734 Oxazinones having antibacterial activity
12/09/2003US6660733 Induce immunology response
12/09/2003US6660732 Ureas and thioureas inhibit production of cytokines
12/09/2003US6660729 Particle-forming compositions containing fused pyrrolocarbazoles
12/09/2003US6660728 Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists
12/09/2003US6660725 Method and composition for modulating amyloidosis
12/09/2003US6660724 Compounds and pharmaceutical compositions containing them
12/09/2003US6660723 Activating primate gamma delta lymphocytes
12/09/2003US6660722 Therapeutical treatments
12/09/2003US6660721 Anti-HCV nucleoside derivatives
12/09/2003US6660719 Inhibiting T-Cell proliferation
12/09/2003US6660715 Nonaqueous solutions and suspensions of macromolecules for pulmonary delivery
12/09/2003US6660525 Therapeutic liposome composition and method
12/09/2003US6660520 Nrde
12/09/2003US6660468 Vitro and in vivo models for screening compounds to prevent glucocorticoid-induced bone destruction
12/09/2003US6660466 Reacting reactive appendage compounds such as meta benzylic compounds or alpha-amide compounds with scaffold molecules having reactive functionalities and contacting the intermediate library with a reducing agent
12/09/2003US6660308 Beverage and additive for the ill
12/09/2003US6660304 Method of treating prickly heat
12/09/2003US6660300 Antidiabetic metformin HCl salt; high water solubility and a limited window of absorption; hydrophilic and hydrophobic polymers
12/09/2003US6660299 Treating a bacterial infection in a human by administering a specified high dosage of amoxycillin over given time
12/09/2003US6660298 Acidulant and a water dispersible polymer to solubilize sufficient paroxetine hydrochloride
12/09/2003US6660297 Nutritional supplement to treat macular degeneration
12/09/2003US6660296 Neutral granular support coated with an active layer comprising: Diltiazem or a salt, a surfactant, and a binder, and a layer which ensures sustained release of the active principle
12/09/2003US6660293 Carotenoids; vitamins E, D, & C; thiamine; riboflavin; niacin; folic acid; pyridoxine; biotin; pantothenic acid; cobalamin; magnesium; manganese; zinc; selenium; chromium; copper; alpha lipoic acid; and lutein; added iron free
12/09/2003US6660289 Disinfecting composition based on H2O2, acids and metal ions
12/09/2003US6660286 Emulsion vehicle for poorly soluble drugs
12/09/2003US6660283 Cinnamic acid or derivatives chosen from mono- and polyhydroxycinnamic acids, alcohols, aldehydes, esters etc. show an effect on lipid synthesis; promote moisturization of the skin; reinforce suppleness of the skin
12/09/2003US6660275 Amplification nucleic acids
12/09/2003US6660268 Proteasome regulation of NF-KB activity
12/09/2003US6660260 Bioprosthetic heart valves
12/09/2003US6660251 Galenic formulation containing biotin
12/09/2003US6660249 Inhalable dry powder aztreonam for treatment and prevention of pulmonary bacterial infections
12/09/2003US6660246 Ligands and metal complexes thereof
12/09/2003US6660024 Tissue penetrating catheters having integral imaging transducers and their methods of use
1 ... 5250 5251 5252 5253 5254 5255 5256 5257 5258 5259 5260 5261 5262 5263 5264 5265 5266 5267 5268 5269 5270 ... 7860